Cargando…

MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys

Continuous glucose monitors (CGMs) can be helpful in management of type 1 diabetes (T1D). Our objectives were to explore parental reason for adding CGM to their child’s T1D management and to describe potential barriers to starting CGM. Prior to CGM initiation, the primary caregiver of a child with T...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhaled, Lina, O’Riordan, MaryAnn, MacLeish, Sarah A, Hazen, Rebecca, Wood, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208916/
http://dx.doi.org/10.1210/jendso/bvaa046.1697
_version_ 1783530958200242176
author Alkhaled, Lina
O’Riordan, MaryAnn
MacLeish, Sarah A
Hazen, Rebecca
Wood, Jamie
author_facet Alkhaled, Lina
O’Riordan, MaryAnn
MacLeish, Sarah A
Hazen, Rebecca
Wood, Jamie
author_sort Alkhaled, Lina
collection PubMed
description Continuous glucose monitors (CGMs) can be helpful in management of type 1 diabetes (T1D). Our objectives were to explore parental reason for adding CGM to their child’s T1D management and to describe potential barriers to starting CGM. Prior to CGM initiation, the primary caregiver of a child with T1D completed validated questionnaires including Fear of Hypoglycemia Scale (FOH), State-Trait Anxiety Inventory (STAI), Problem Areas in Diabetes Scale (PAID), and an investigator developed questionnaire assessing primary reason for starting CGM. Surveys were repeated 3-8 months after adding CGM. The results of the initial surveys reported elsewhere suggest that the most common reason for starting CGM is to improve glycemic control. Out of 32 participants who completed initial surveys and intended to start CGM on their child, only 43% (N=14) started using CGM during the 3-8 month follow up period. Reasons for not starting CGM included: not having the chance to start the process of having it approved by insurance in 64% (N=9), and difficulties getting insurance to approve CGM in 28% (N=4). One participant reported that despite insurance coverage, out of pocket expense was too much. Wilcoxon Rank Sum tests were used to compare demographic variables between those that started and those that did not start CGM. Medians were used to report the results. There were no statistically significant differences between children who did and did not start CGM in terms of age (9.3 vs. 11.4 yrs, P=0.3), baseline HbA1c (8.1% vs. 9.4%, P=0.1), and diabetes duration (3.0 vs. 4.3 yrs, P=0.6). In summary, despite parental interest in CGM initiation for their children with type 1 diabetes, there remains a significant barrier to implementation from delays in getting insurance approval. Revision of policies related to CGM coverage in youth need to be revised and systems in place to expedite approval.
format Online
Article
Text
id pubmed-7208916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72089162020-05-13 MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys Alkhaled, Lina O’Riordan, MaryAnn MacLeish, Sarah A Hazen, Rebecca Wood, Jamie J Endocr Soc Pediatric Endocrinology Continuous glucose monitors (CGMs) can be helpful in management of type 1 diabetes (T1D). Our objectives were to explore parental reason for adding CGM to their child’s T1D management and to describe potential barriers to starting CGM. Prior to CGM initiation, the primary caregiver of a child with T1D completed validated questionnaires including Fear of Hypoglycemia Scale (FOH), State-Trait Anxiety Inventory (STAI), Problem Areas in Diabetes Scale (PAID), and an investigator developed questionnaire assessing primary reason for starting CGM. Surveys were repeated 3-8 months after adding CGM. The results of the initial surveys reported elsewhere suggest that the most common reason for starting CGM is to improve glycemic control. Out of 32 participants who completed initial surveys and intended to start CGM on their child, only 43% (N=14) started using CGM during the 3-8 month follow up period. Reasons for not starting CGM included: not having the chance to start the process of having it approved by insurance in 64% (N=9), and difficulties getting insurance to approve CGM in 28% (N=4). One participant reported that despite insurance coverage, out of pocket expense was too much. Wilcoxon Rank Sum tests were used to compare demographic variables between those that started and those that did not start CGM. Medians were used to report the results. There were no statistically significant differences between children who did and did not start CGM in terms of age (9.3 vs. 11.4 yrs, P=0.3), baseline HbA1c (8.1% vs. 9.4%, P=0.1), and diabetes duration (3.0 vs. 4.3 yrs, P=0.6). In summary, despite parental interest in CGM initiation for their children with type 1 diabetes, there remains a significant barrier to implementation from delays in getting insurance approval. Revision of policies related to CGM coverage in youth need to be revised and systems in place to expedite approval. Oxford University Press 2020-05-08 /pmc/articles/PMC7208916/ http://dx.doi.org/10.1210/jendso/bvaa046.1697 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Alkhaled, Lina
O’Riordan, MaryAnn
MacLeish, Sarah A
Hazen, Rebecca
Wood, Jamie
MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title_full MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title_fullStr MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title_full_unstemmed MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title_short MON-097 Continuous Glucose Monitoring in Youth with Type 1 Diabetes; Parental Anxiety and Parent Defined Outcomes: Results of Follow up Surveys
title_sort mon-097 continuous glucose monitoring in youth with type 1 diabetes; parental anxiety and parent defined outcomes: results of follow up surveys
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208916/
http://dx.doi.org/10.1210/jendso/bvaa046.1697
work_keys_str_mv AT alkhaledlina mon097continuousglucosemonitoringinyouthwithtype1diabetesparentalanxietyandparentdefinedoutcomesresultsoffollowupsurveys
AT oriordanmaryann mon097continuousglucosemonitoringinyouthwithtype1diabetesparentalanxietyandparentdefinedoutcomesresultsoffollowupsurveys
AT macleishsaraha mon097continuousglucosemonitoringinyouthwithtype1diabetesparentalanxietyandparentdefinedoutcomesresultsoffollowupsurveys
AT hazenrebecca mon097continuousglucosemonitoringinyouthwithtype1diabetesparentalanxietyandparentdefinedoutcomesresultsoffollowupsurveys
AT woodjamie mon097continuousglucosemonitoringinyouthwithtype1diabetesparentalanxietyandparentdefinedoutcomesresultsoffollowupsurveys